IL132154A - אפרוסטרן ושימושו כתרופה לטיפול בלחץ דם סיסטולי גבוה מבודד - Google Patents

אפרוסטרן ושימושו כתרופה לטיפול בלחץ דם סיסטולי גבוה מבודד

Info

Publication number
IL132154A
IL132154A IL13215498A IL13215498A IL132154A IL 132154 A IL132154 A IL 132154A IL 13215498 A IL13215498 A IL 13215498A IL 13215498 A IL13215498 A IL 13215498A IL 132154 A IL132154 A IL 132154A
Authority
IL
Israel
Prior art keywords
eprosartan
systolic hypertension
medicament
isolated systolic
treating isolated
Prior art date
Application number
IL13215498A
Other languages
English (en)
Other versions
IL132154A0 (en
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL132154A0 publication Critical patent/IL132154A0/xx
Publication of IL132154A publication Critical patent/IL132154A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Fixed Capacitors And Capacitor Manufacturing Machines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL13215498A 1997-05-27 1998-05-27 אפרוסטרן ושימושו כתרופה לטיפול בלחץ דם סיסטולי גבוה מבודד IL132154A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4780097P 1997-05-27 1997-05-27
PCT/US1998/010794 WO1998053816A1 (en) 1997-05-27 1998-05-27 Method of treating isolated systolic hypertension

Publications (2)

Publication Number Publication Date
IL132154A0 IL132154A0 (en) 2001-03-19
IL132154A true IL132154A (he) 2002-12-01

Family

ID=21951046

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13215498A IL132154A (he) 1997-05-27 1998-05-27 אפרוסטרן ושימושו כתרופה לטיפול בלחץ דם סיסטולי גבוה מבודד

Country Status (24)

Country Link
US (1) US20020040045A1 (he)
EP (1) EP1003506B1 (he)
JP (1) JP2002500673A (he)
KR (1) KR20010013014A (he)
CN (1) CN1257427A (he)
AR (1) AR012872A1 (he)
AT (1) ATE307580T1 (he)
AU (1) AU740646B2 (he)
BR (1) BR9809611A (he)
CA (1) CA2288722C (he)
CZ (1) CZ298390B6 (he)
DE (1) DE69832075T2 (he)
ES (1) ES2251083T3 (he)
HU (1) HUP0003249A3 (he)
IL (1) IL132154A (he)
MX (1) MXPA99010970A (he)
NO (1) NO326141B1 (he)
NZ (1) NZ337888A (he)
PL (1) PL191971B1 (he)
SA (1) SA98190174B1 (he)
TR (1) TR199902914T2 (he)
TW (1) TW579296B (he)
WO (1) WO1998053816A1 (he)
ZA (1) ZA984421B (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006076097A2 (en) * 2004-12-07 2006-07-20 Nektar Therapeutics Stable non-crystalline formulation comprising losartan

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US544080A (en) * 1895-08-06 Centrifugal filtering-machine
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
JPH05199342A (ja) * 1991-05-20 1993-08-06 Xerox Corp 無声の手書きによる携帯式通信装置および方法

Also Published As

Publication number Publication date
EP1003506B1 (en) 2005-10-26
CA2288722C (en) 2007-04-24
CN1257427A (zh) 2000-06-21
CZ298390B6 (cs) 2007-09-19
AU740646B2 (en) 2001-11-08
AU7601798A (en) 1998-12-30
BR9809611A (pt) 2000-07-04
US20020040045A1 (en) 2002-04-04
NO995797L (no) 1999-11-26
CZ420099A3 (cs) 2000-09-13
CA2288722A1 (en) 1998-12-03
TW579296B (en) 2004-03-11
NO995797D0 (no) 1999-11-26
HUP0003249A3 (en) 2002-02-28
ZA984421B (en) 1998-11-27
WO1998053816A1 (en) 1998-12-03
SA98190174B1 (ar) 2006-05-13
NO326141B1 (no) 2008-10-06
DE69832075D1 (de) 2005-12-01
NZ337888A (en) 2001-04-27
PL191971B1 (pl) 2006-07-31
DE69832075T2 (de) 2006-07-13
IL132154A0 (en) 2001-03-19
KR20010013014A (ko) 2001-02-26
ES2251083T3 (es) 2006-04-16
ATE307580T1 (de) 2005-11-15
AR012872A1 (es) 2000-11-22
MXPA99010970A (es) 2005-07-25
PL336886A1 (en) 2000-07-17
HUP0003249A2 (hu) 2002-01-28
TR199902914T2 (xx) 2000-06-21
EP1003506A1 (en) 2000-05-31
JP2002500673A (ja) 2002-01-08
EP1003506A4 (en) 2000-11-29

Similar Documents

Publication Publication Date Title
MXPA00002784A (es) Sistema basado en modelo estadistco multivariado pra verificar la operacion de un fundidor continuo y detectar la aparicion de rebabas por rotura de molde inminentes.
AU781827B2 (en) Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation
Borghi et al. Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial
US20020077328A1 (en) Selective cyclooxygenase-2 inhibitors and vasomodulator compounds for generalized pain and headache pain
WO2003024456A1 (en) Methods for treating and preventing migraines
HU219404B (hu) Eljárás kardiális és vaszkuláris hipertrófia és/vagy hiperplazia kezelésére alkalmas angiotenzin-II-receptor blokkoló hatású vegyületet tartalmazó gyógyszerkészítmények előállítására
JPH07504659A (ja) Ａｃｅ阻害剤及び利尿剤の併用
EP0561977B1 (en) Use of angiotensin ii receptor antagonists in the treatment of hemorragic stroke
EP0660713B1 (en) Use of angiotensin ii antagonists in the treatment of left ventricular hypertrophy
CA2288722C (en) Method of treating isolated systolic hypertension
RU2182002C2 (ru) Композиция с фиксированной дозой ингибитора ангиотензин-превращающего фермента и антагониста кальциевых каналов, способ ее изготовления и применение для лечения сердечно-сосудистых заболеваний
EA007952B1 (ru) Применение ирбесартана для изготовления лекарств, которые пригодны для предупреждения или лечения лёгочной артериальной гипертензии
US20010005723A1 (en) Method of treating isolated systolic hypertension
US20050113431A1 (en) Method of treating isolated systolic hypertension
AU7559501A (en) Method of treating isolated systolic hypertension
JPH0532635A (ja) ヒスタミン誘導体の治療への応用と、新規なヒスタミン誘導体と、この誘導体の医薬としての使用
CA1110170A (en) Antihypertensive compositions
US4189492A (en) Antihypertensive compositions of 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole and N-(2-chloroethyl)-N-(1-methyl-2-phenoxy-ethyl)benzenemethanamine
JPH04279524A (ja) 脳血管疾患治療剤
EP0303357A2 (en) 4-Amino-6,7-dimethoxy-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl)quinoline for (treatment of cardiac arrhythmias).
KR100222627B1 (ko) 앙기오텐신-ii 수용체 길항제 및 칼슘 채널 차단제의 신규한 조성물
Weber Prolonged calcium channel blocker therapy of hypertension
CA2498049A1 (en) At<sb>1</sb> receptor antagonists for preventing secondary strokes

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees